Cancer Family
Neck Neoplasm
CI-CAN-00000283Explore in graph →
Non-malignant634 active trials11 approved drugs67 evidence items
- NCIt
- C3260
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000283Explore in graph →
Clinical trials
2,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00251316 | Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer | completed | Phase 2 | 34 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00305734 | Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 |
| clinicaltrials |
| NCT00064103 | Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx | completed | Phase 1 / Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00063895 | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 9, 2013 | clinicaltrials |
| NCT01739634 | The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | unknown | Phase 1 / Phase 2 | 10 | Salient Pharmaceuticals IncorporatedINDUSTRY | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00592319 | Celebrex (Celecoxib) Treatment of Laryngeal Papilloma | terminated | Phase 2 | 10 | Boston UniversityOTHER | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00778908 | Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma | completed | Phase 2 / Phase 3 | 120 | Guangxi Medical UniversityOTHER | 1 | Aug 21, 2012 | clinicaltrials |
| NCT01655628 | GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00094055 | Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer | completed | Phase 2 | 60 | PfizerINDUSTRY | 1 | Jun 26, 2012 | clinicaltrials |
| NCT01616316 | Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients | completed | Phase 2 / Phase 3 | 86 | Samsung Medical CenterOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT01614938 | Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer | unknown | Phase 2 | 46 | Fudan UniversityOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00212108 | A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 | completed | Phase 1 / Phase 2 | 22 | National University Hospital, SingaporeOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT01516996 | Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | unknown | Phase 2 | 80 | The Second People's Hospital of SichuanOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00697619 | To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer | completed | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT00630149 | Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy | completed | Phase 2 | 35 | Sun Yat-sen UniversityOTHER | 1 | Feb 16, 2012 | clinicaltrials |
| NCT00279721 | Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer. | completed | Phase 2 | 40 | Alberta Health servicesOTHER | 0 | Jan 19, 2012 | clinicaltrials |
| NCT01449942 | Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma(NPC-DZ) | completed | Phase 1 / Phase 2 | 40 | Xiangya Hospital of Central South UniversityOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT00941135 | Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab | terminated | Phase 2 | 70 | Fundacion Miguel ServetOTHER | 1 | Sep 29, 2011 | clinicaltrials |
| NCT01086488 | Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma(FOSCAN) | unknown | Phase 2 | 66 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00169247 | Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation | completed | Phase 2 | 156 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Jun 27, 2011 | clinicaltrials |
| NCT01312311 | Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer | unknown | Phase 2 | 51 | Samsung Medical CenterOTHER | 1 | Mar 10, 2011 | clinicaltrials |
| NCT00786552 | Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer(Panthera) | unknown | Phase 2 | 47 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT01265147 | Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma | unknown | Phase 2 | 20 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT00436293 | Taxotere + Cisplatin in Nasopharyngeal Carcinoma | completed | Phase 2 | 61 | SanofiINDUSTRY | 1 | Nov 17, 2010 | clinicaltrials |
| NCT00363831 | Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 42 | The University of Hong KongOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT00634595 | Trial of E10A in Head and Neck Cancer | unknown | Phase 2 | 116 | Sun Yat-sen UniversityOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT00647140 | Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer(DOPMET) | terminated | Phase 2 | 29 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00700440 | Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy(ENCORE) | completed | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Mar 26, 2010 | clinicaltrials |
| NCT01073683 | Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer | unknown | Phase 2 | 100 | Rabin Medical CenterOTHER | 1 | Mar 5, 2010 | clinicaltrials |
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00123864 | Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function | completed | Phase 1 / Phase 2 | 25 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00176748 | Treatment for Patients With Metastatic Thyroid Cancer | completed | Phase 2 | 3 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00436800 | Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00887107 | Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma | completed | Phase 2 | 32 | Leiden University Medical CenterOTHER | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)(TPF for NPC) | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00817258 | Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma | unknown | Phase 2 | 37 | Fudan UniversityOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | unknown | Phase 2 | 64 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | unknown | Phase 2 | 52 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00080574 | The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients | completed | Phase 2 | 20 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00251381 | Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. | unknown | Phase 2 | 90 | Trial Form Support S.L.OTHER | 1 | Oct 26, 2006 | clinicaltrials |
| NCT00026975 | Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients | completed | Phase 2 | 150 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Feb 4, 2013source: clinicaltrials